Literature DB >> 9112482

The use of kidneys from living donors with renal vascular disease: expanding the donor pool.

D P Serrano1, S M Flechner, C S Modlin, S B Streem, D A Goldfarb, A C Novick.   

Abstract

PURPOSE: The disparity between the number of patients awaiting organ transplantation and the number of available donor organs continues to increase. We report the outcomes of transplantation using kidneys from living donors who had unilateral renovascular disease.
MATERIALS AND METHODS: We identified 5 living donors who had unilateral renovascular disease, including saccular renal artery aneurysms, an arteriovenous malformation, localized atherosclerosis and fibromuscular renal artery stenosis. Each donor was normotensive and asymptomatic, and had otherwise normal renal function.
RESULTS: In each case the abnormal kidney was removed, the lesion was repaired ex vivo and the kidney was successfully transplanted without complication in the donor or recipient. Each recipient had a serum creatinine of less than 2 mg./dl. and each donor remained normotensive with stable renal function at up to 3 years of followup.
CONCLUSIONS: Kidneys from living donors with renovascular disease can be transplanted safely provided that careful selection, informed consent and a normal remaining kidney are ensured.

Entities:  

Mesh:

Year:  1997        PMID: 9112482

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  2 in total

1.  Long-term graft outcome after renal arterial reconstruction during living related kidney transplantation.

Authors:  Tolga Atilla Sagban; Barbara Baur; Lars Christian Rump; Hubert Schelzig; Klaus Grabitz; Kai Michael Balzer
Journal:  Langenbecks Arch Surg       Date:  2014-01-24       Impact factor: 3.445

2.  A case of a living-related kidney transplantation after ex-vivo repair of the donor renal artery aneurysm.

Authors:  P Christopoulos; A Faryal; M Dosani; D Rix; D Talbot
Journal:  Hippokratia       Date:  2016 Jan-Mar       Impact factor: 0.471

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.